Neuroblastoma | CHOP Research Institute
 

Neuroblastoma

Published on
May 7, 2025
Using advanced omics and computational techniques, the researchers found that both cancer and immune cells changed after treatment.
Published on
Apr 3, 2025
PEEL-224, a therapy to treat high-risk tumors, enters a pediatric clinical trial after a decade of groundbreaking research.

This study enrolls patients with refractory, progressive, or relapsed solid tumors.

Published on
Mar 21, 2025
This week’s In The News highlights the legacy of Dr. Audrey Evans, newly elected AACR fellows, and a novel approach for rare disease.
Published on
Dec 19, 2024
As the pediatric cancer charity celebrates its 20th anniversary, Cornerstone is highlighting the groundbreaking research at CHOP fueled by two decades of collaboration.
Published on
Dec 5, 2024
CHOP researchers are looking to enhance the understanding of the possible genetic links between childhood cancers and structural birth defects.
Published on
Nov 22, 2024
Congratulations to physician scientist Dr. Yael Mosse, who received a Penn Medicine Award of Excellence for her contributions to pediatric oncology, and more.
Published on
Nov 6, 2024
Researchers identify cell surface protein DLK1 as a potential immunotherapeutic target for neuroblastoma.
Published on
Oct 30, 2024
Adam Wolpaw, MD, PhD, and Timothy Spear, MD, PhD, have been awarded grants from Hyundai Hope On Wheels to improve CAR T-cell therapy.
Published on
Oct 11, 2024
In The News this week, we celebrate CHOP being named a top children’s hospitals in the nation for the 17th consecutive year.